Information for "Your miR3613p improves enzalutamide Enz sensitivity by means of targeting the ARv7 and MKNK2 to raised reduce the actual Enzresistant prostate cancer"
From EECH Central
Basic information
Display title | Your miR3613p improves enzalutamide Enz sensitivity by means of targeting the ARv7 and MKNK2 to raised reduce the actual Enzresistant prostate cancer |
Default sort key | Your miR3613p improves enzalutamide Enz sensitivity by means of targeting the ARv7 and MKNK2 to raised reduce the actual Enzresistant prostate cancer |
Page length (in bytes) | 3,538 |
Page ID | 1406764 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Robindollar72 (Talk | contribs) |
Date of page creation | 07:44, 26 April 2024 |
Latest editor | Robindollar72 (Talk | contribs) |
Date of latest edit | 07:44, 26 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |